glp 1 disorders A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative The GLP-1 journey: from discovery

The common indication among all GLP-1 drugs is type 2 diabetes: they are prescribed for patients whose hemoglobin A1C is greater than 8.5%, who have a need for weight loss and who have a need to avoid hypoglycemia

Soares-da-Silva P, Fernandes MH, Pinto-do-O PC

(Anacardiaceae) on Superoxide Radical Scavenging and Xanthine Oxidase Activity, Journal of Enzyme Inhibition and Medicinal Chemistry 18 (2003): 5962, 10.1080/1475636031000069273

It was one of the first synthetic GH-releasing peptides characterized, containing D-tryptophan at position 2 and D-phenylalanine at position 5

By using them in tandem, you may see enhanced results compared to using either medication alone

The choice between injection and oral forms often depends on personal preference and consistency